BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• BioMidwest

  Gilson Demonstrates First Cloud-Connected Liquid Handling Tools at Analytica 2018

  Gilson Connect includes the company’s first Internet of Things (IoT) products.

  February 21, 2019

   · 

  4 min read
• Business

  Allogene Therapeutics Enters Lease to Build Manufacturing Facility to Develop and Commercialize Allogeneic CAR T (AlloCAR T™) Therapies

  • State-of-the-Art Manufacturing Facility to be Located in the San Francisco East Bay Area • Allogene Committed to Advanced Cell Manufacturing for Long-Term Clinical and Commercial AlloCAR T™ Production

  February 21, 2019

   · 

  4 min read
• ‘Japan second fastest pharma growth in 2019’ CPhI Japan report

  The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead of CPhI Japan 2019.

  February 21, 2019

   · 

  7 min read
• Dermavant Sciences to Present Data on Tapinarof for Psoriasis and Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting

  Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, today announced that the company will present data on tapinarof at the 2019 American Academy of Dermatology (AAD) Annual Meeting taking place March 1-5, 2019, in Washington, D.C.

  February 21, 2019

   · 

  2 min read
• Business

  Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies

  Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announce a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines.

  February 21, 2019

   · 

  2 min read
• Department of Defense Lung Cancer Research Program: Anticipated Funding Opportunities for Fiscal Year 2019 (FY19)

  The FY19 Defense Appropriation provides $14 million (M) to the Department of Defense Lung Cancer Research Program (LCRP) to support innovative, high-impact lung cancer research.

  February 21, 2019

   · 

  3 min read
• Job Trends

  Flinn Foundation Program Tops $1M in Funding Support with Selection of Six Arizona Bioscience Startup Firms

  The Flinn Foundation has surpassed $1 million in funding support to benefit Arizona bioscience startup companies with the selection of six firms to participate in the foundation’s 2019 Bioscience Entrepreneurship Program.

  February 21, 2019

   · 

  4 min read
• Drug Development

  AIVITA Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial

  AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that its first patient has completed treatment in its multi-center Phase 2 ROOT OF CANCER ovarian cancer trial.

  February 21, 2019

   · 

  4 min read
• Business

  Cell & Gene Immunotherapy Biotech, Vycellix, to Establish Headquarters in Tampa

  Vycellix™, Inc. announced that the Company, founded by leading medical researchers at Sweden’s world renowned Karolinska Institutet, will establish its U.S. headquarters in Tampa, Florida.

  February 21, 2019

   · 

  4 min read
• Genetown

  Quanterix to Present at Multiple Upcoming Healthcare Conferences

  Chief Executive Officer will speak at the Leerink Partners Global Healthcare Conference and the Cowen and Company Health Care Conference

  February 21, 2019

   · 

  2 min read